Engineering synthetic enhancers and gene circuits to understand and overcome cancer therapy resistance
Fördersumme: € 899.099
Second generation human papillomavirus (HPV) vaccine for broad-spectrum protection against HPV-induced skin and mucosal neoplasia
Dauer: 60 Monate, Fördersumme: € 800.000
Tumor-infiltrating CD20+ B cells: Promoters of human melanoma?
Dauer: 60 Monate, Fördersumme: € 767.400